We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Meditech (MTCH) Viraplex - possible cancer treatment
An SI Board Since June 1998
Posts SubjectMarks Bans Symbol
39 1 0 MTCH
Emcee:  Elliot Type:  Unmoderated
Meditech's Viraplex(R) Test Drug for Cancer Overcomes Hurdle

SCOTTSDALE, Ariz., June 1 /PRNewswire/ -- Meditech Pharmaceuticals Inc. (OTC Bulletin Board: MTCH - news) said researchers at the School of Pharmacy at the University of London have now successfully developed a new form of the drug Viraplex(R), which renders it soluble. Meditech has been developing this drug for over 12 years including testing done by the National Cancer Institute (NCI) for the treatment of certain types of cancers.

The UK researchers who have been working on this project have now prepared a proposal to produce a sufficient quantity of the reformulated compound for two simultaneous testing programs.

Viraplex(R) gave positive in vitro results against several forms of cancer, including breast, prostate and lung tumors. The in vivo tests proved inconclusive due to solubility problems which made it difficult to administer a therapeutic dose to the human tumor cells that had been implanted in the test animals. Because an optimal serum level could not be achieved, the drug was not at that point of its dose-response curve where it earlier had been shown to be effective against these tumors. It appears that the problem has now been solved.

First, Meditech will provide NCI with enough of the soluble form of the drug to resume testing. If this form of the drug maintains its efficacy, it will be retested in the animal studies. It is anticipated that the costs of these tests will likely be construed by NCI.

Second, Meditech wishes to retest this new formulation of the active ingredient in Viraplex(R) against the Herpes simplex virus in animal studies. Colleagues of our principal researcher at the London School of Pharmacy who have experience in designing and conducting such tests are now estimating the costs and timing of these tests. Meditech has been told to expect their proposals later this year.

Some additional funding will be required to underwrite the ongoing research in the United Kingdom.

Meditech's future results of operations and other forward looking statements contained in this document involve a number of risks and uncertainties. Factors which could cause results to differ materially include business conditions, the general economy, competitive activity, government regulation, failure to achieve necessary funding support as well as others.

SOURCE: Meditech Pharmaceuticals, Inc.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
38 TO: ALL Reported for informational purposes only Courtesy of the Raging Bull OLD JAKE JUSTUS-6/8/1999
37 TO: ALL >>>>> This post is directed to no one in particular. I OLD JAKE JUSTUS-6/7/1999
36 The below was posted on another thread. It must have caught the eyes of some foOLD JAKE JUSTUS-6/7/1999
35 I didn't see any news. Trying to recoup here too. But had a couple of otherElliot-6/7/1999
34 What woke this dog up Friday...heavy afternoon trading with no visible news. I&Dave B-6/5/1999
33 Forget about it. Check out CELN instead.
32 Did anyone see that 1,000,000 share trade at the ask today?? I read the quarteLee Walsh-1/29/1999
31 i dont think they are doing much of a job of promotion but the mms seem to be Mike P.-12/31/1998
30 All remains quiet here. No news since July. Unfortunately they have paid certElliot-12/31/1998
29 action caught my eye today too never heard of them, no interest on the interneMike P.-11/19/1998
28 Does anyone know what's going on here today.... Anyone talked to the compaLee Walsh-11/19/1998
27 No news yet. - Holding. Blayton-9/21/1998
26 Does anyone have any information regarding the ongoing clinical trials/lab testJimmyT-9/21/1998
25 I've been in since May. Can't stay too much longer. T/A tends to indBlayton-8/13/1998
24 Hello all I bought MTCH in July of 1989! Been sitting on 3000 shares ever sinJeffA-8/13/1998
23 You're talking about this one, MTCH? Well, fortunately I did not buy any. Howard C.-8/6/1998
22 Well Mr. C. looks like another million shares is gonna be dumped on the market.HRAKA-8/6/1998
21 There have been rumors, totally unsubstantiated so far. Who knows? I have notHoward C.-7/25/1998
20 I found this is it true ? HOT STOCK!!! sec_friends (45/M/New York, NY) Jul 24slyfoxhunter-7/24/1998
19 Don't all speak at once, now.Howard C.-7/22/1998
18 Volume picking up today....Howard C.-7/9/1998
17 I beat ya this time! I can sniff 'em out. (same reason as yours I"m Howard C.-7/9/1998
16 Can someone give me the transfer agent's number? Also a number for the compHRAKA-7/9/1998
15 I'm considering an investment on this one. Any new news? Any definitive sHoward C.-7/9/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):